Trial
NCT02676765
Desensitization and Cross-Desensitization During Oral Grass or Ragweed Pollen Immunotherapy
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Virginia Commonwealth University
Collaborators
—
Condition
Immunologic Desensitization
Intervention
allergen extract tablet
Why stopped
Intellectual property issues with drug manufacture.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-18